Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
Isabelle Aillaud, Susanne Aileen Funke
Cellular and Molecular Neurobiology (2022) Vol. 43, Iss. 3, pp. 951-961
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Multifunctional nanoparticle-mediated combining therapy for human diseases
Xiaotong Li, Xiuju Peng, Makhloufi Zoulikha, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 125
Tau-targeting therapies for Alzheimer disease: current status and future directions
Erin E. Congdon, Changyi Ji, Amber M. Tetlow, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 12, pp. 715-736
Closed Access | Times Cited: 121
Advances in Alzheimer's disease: A multifaceted review of potential therapies and diagnostic techniques for early detection
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta
Neurochemistry International (2024) Vol. 177, pp. 105761-105761
Closed Access | Times Cited: 16
Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets
Zdeněk Fišar
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1676-1676
Open Access | Times Cited: 53
Quantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectations and limitations
Yuto Uchida, Hirohito Kan, Keita Sakurai, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 45
Genetic engineering of bacteriophages: Key concepts, strategies, and applications
Wajid Hussain, Xiaohan Yang, Mati Ullah, et al.
Biotechnology Advances (2023) Vol. 64, pp. 108116-108116
Closed Access | Times Cited: 27
Modulation of Tau Pathology in Alzheimer’s Disease by Dietary Bioactive Compounds
Huahua Shi, Yan Zhao
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 831-831
Open Access | Times Cited: 6
Tau- and α-synuclein-targeted gold nanoparticles: applications, opportunities, and future outlooks in the diagnosis and therapy of neurodegenerative diseases
Andreas Tapia-Arellano, Pablo Cabrera, Elizabeth Cortés-Adasme, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
(−)-Epigallocatechin-3-gallate, a Polyphenol from Green Tea, Regulates the Liquid–Liquid Phase Separation of Alzheimer’s-Related Protein Tau
Jingxin Chen, Wanyao Ma, Jiangchuan Yu, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 4, pp. 1982-1993
Closed Access | Times Cited: 12
Precision proteoform design for 4R tau isoform selective templated aggregation
Andrew P. Longhini, Austin DuBose, Samuel Lobo, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 15
Open Access | Times Cited: 4
Iron accumulation/overload and Alzheimer's disease risk factors in the precuneus region: A comprehensive narrative review
Sana Mohammadi, Sadegh Ghaderi, Farzad Fatehi
Aging Medicine (2024) Vol. 7, Iss. 5, pp. 649-667
Open Access | Times Cited: 4
Functional Analysis of Direct In Vitro Effect of Phosphorylated Tau on Mitochondrial Respiration and Hydrogen Peroxide Production
Zdeněk Fišar, Jana Hroudová
Biomolecules (2025) Vol. 15, Iss. 4, pp. 495-495
Open Access
Advances in Alzheimer’s Disease-Associated Aβ Therapy Based on Peptide
Cunli Wang, Shuai Shao, Na Li, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13110-13110
Open Access | Times Cited: 9
Macrocyclic peptides derived from AcPHF6* and AcPHF6 to selectively modulate the Tau aggregation
Abha Dangi, Tazeen Qureshi, Subashchandrabose Chinnathambi, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107625-107625
Closed Access | Times Cited: 3
A novel peptide‐based tau aggregation inhibitor as a potential therapeutic for Alzheimer's disease and other tauopathies
Anthony Aggidis, George Devitt, Yongrui Zhang, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 11, pp. 7788-7804
Open Access | Times Cited: 3
Investigating the effects of Thymus vulgaris essential oil, Allium cepa extract, and their active compounds (thymol and quercetin) on expression profile of genes related to Alzheimer's disease in PC12 model cell
saba Foroughi, Kahin Shahanipour, Ramesh Monajemi, et al.
Brain Research (2024) Vol. 1838, pp. 148966-148966
Closed Access | Times Cited: 2
Tau Protein and Tauopathies: Exploring Tau Protein‐Protein and Microtubule Interactions, Cross‐Interactions and Therapeutic Strategies.
Davide di Lorenzo
ChemMedChem (2024) Vol. 19, Iss. 21
Open Access | Times Cited: 2
Quercetagitrin Inhibits Tau Accumulation and Reverses Neuroinflammation and Cognitive Deficits in P301S-Tau Transgenic Mice
Suyue Zhong, Jinwang Ye, Yunsong Deng, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3964-3964
Open Access | Times Cited: 5
PSEN1 E280A Cholinergic-like Neurons and Cerebral Spheroids Derived from Mesenchymal Stromal Cells and from Induced Pluripotent Stem Cells Are Neuropathologically Equivalent
Miguel Mendivil‐Perez, Carlos Velez‐Pardo, Francisco Lopera, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8957-8957
Open Access | Times Cited: 5
Evaluation of large language models for discovery of gene set function
Dexter Pratt, Mengzhou Hu, Sahar Alkhairy, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 5
The past and present of therapeutic strategy for Alzheimer's diseases—potential for stem cell therapy
Masanori A. Murayama
EXPERIMENTAL ANIMALS (2023) Vol. 72, Iss. 3, pp. 285-293
Open Access | Times Cited: 4
β-Bracelets: Macrocyclic Cross-β Epitope Mimics Based on a Tau Conformational Strain
Benjamin H. Rajewski, Kamlesh M. Makwana, Isaac J. Angera, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 42, pp. 23131-23142
Closed Access | Times Cited: 4
EB1 Increases the Dynamics of Tau Droplets and Inhibits Tau Aggregation: Implications in Tauopathies
Anuradha Venkatramani, Anvesh Ashtam, Dulal Panda
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 6, pp. 1219-1233
Closed Access | Times Cited: 1
Kallikrein-related peptidase's significance in Alzheimer's disease pathogenesis: A comprehensive survey
Rilès Boumali, Laureline Urli, Meriem Naïm, et al.
Biochimie (2024) Vol. 226, pp. 77-90
Closed Access | Times Cited: 1
Peptide-based inhibitors and nanoparticles: Emerging therapeutics for Alzheimer’s disease
Solmaz Mojarad-Jabali, Kyung‐Ho Roh
International Journal of Pharmaceutics (2024), pp. 125055-125055
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top